Researcher.Life Logo

EJNMMI Research : Impact Factor & More

eISSN: 2191-219XpISSN: 2191-219X
JournalOpen Access

Aims and Scope of EJNMMI Research

EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging. Regular features include original research articles, rapid communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor. Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome. Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.The main emphasis is placed on the development of targeted imaging with radiopharmaceuticals within the broader context of molecular probes to enhance understanding and characterisation of the complex biological processes underlying disease and to develop, test and guide new treatment modalities, including radionuclide therapy. Less

Key Metrics

CiteScore
4.6
Impact Factor
< 5
SJR
Q2Radiology, Nuclear Medicine and Imaging
SNIP
0.96
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on EJNMMI Research

EJNMMI Research Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SPRINGER
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2390 | USD 2890 | GBP 1990
Publication Time13
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorEuropean Association of Nuclear Medicine (EANM)
FrequencyContinuous publication
Publication Start Year2011
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 13
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in EJNMMI Research ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in EJNMMI Research

68Ga]Ga-FAPI-04 PET/CT for subtyping and prognostication of IgG4-related disease.
  • 13 May 2026
  • EJNMMI research
Subcutaneous injection of semaglutide causes increased muscle uptake of 18F-FDG and reduces the imaging quality of PET/CT: a case report.
  • 12 May 2026
  • EJNMMI research
Integrated 68Ga-PSMA PET/MRI models improve prostate cancer diagnosis and ISUP stratification, especially in the low-PSA cohort.
  • 9 May 2026
  • EJNMMI research
68Ga-pentixafor PET/CT imaging characteristics in primary aldosteronism with coexisting subclinical cushing syndrome: a retrospective cohort study.
  • 7 May 2026
  • EJNMMI research
Prospective comparison of [68Ga]Ga-FAPI-04 PET/CT and salivary gland scintigraphy for the diagnosis of primary Sjögren's syndrome.
  • 5 May 2026
  • EJNMMI research
Translational development of an SGLT2-targeted near-infrared contrast agent for intraoperative imaging of early-stage lung cancer.
  • 4 May 2026
  • EJNMMI research
68Ga]Ga-FAPI-04 PET/CT for subtyping and prognostication of IgG4-related disease.
  • 13 May 2026
  • EJNMMI research
Subcutaneous injection of semaglutide causes increased muscle uptake of 18F-FDG and reduces the imaging quality of PET/CT: a case report.
  • 12 May 2026
  • EJNMMI research
Integrated 68Ga-PSMA PET/MRI models improve prostate cancer diagnosis and ISUP stratification, especially in the low-PSA cohort.
  • 9 May 2026
  • EJNMMI research
68Ga-pentixafor PET/CT imaging characteristics in primary aldosteronism with coexisting subclinical cushing syndrome: a retrospective cohort study.
  • 7 May 2026
  • EJNMMI research
Prospective comparison of [68Ga]Ga-FAPI-04 PET/CT and salivary gland scintigraphy for the diagnosis of primary Sjögren's syndrome.
  • 5 May 2026
  • EJNMMI research
Translational development of an SGLT2-targeted near-infrared contrast agent for intraoperative imaging of early-stage lung cancer.
  • 4 May 2026
  • EJNMMI research

FAQs on EJNMMI Research